Remove 2010 Remove Concentrates Remove Therapy
article thumbnail

Terpene Spotlight: Pinene

FloridaMarijuana.net

Additionally, the team stated that “Terpenes are also presented as skin penetration enhancers and agents involved in the prevention and therapy of several inflammatory diseases. Additionally, Pinene will boost concentration and alertness. Boca Raton: CRC Press; 2010. Pinene, naturally, has an aroma of pine.

Terpenes 180
article thumbnail

Using Cannabis for Diabetic Nerve Pain

Veriheal

A 2010 study published in the American Family Physician found that around 50% of those with diabetes experience diabetic neuropathy, which can also affect one’s quality of sleep and may even lead to depression. A Promising Study on Cannabis Therapy for Diabetic Symptoms.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Weekly Legislative Roundup 2/22

NORML

Legislation is pending, House Bill 2149, to amend the definition of “cannabis” under the 2010 voter-approved medical marijuana law. Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. NV resident? New Hampshire.

article thumbnail

Intro to CBG

CannaMD

CBGA concentrations are typically greatest in the early stage of the cannabis plant’s growth. CB1 receptors are concentrated primarily in the brain and central nervous system, and have an affinity for psychoactive cannabinoid, THC. As additional research is conducted, these and other claims may be further substantiated.

article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

Borrowing from what is already known about safe circulating levels in patients for generic cepharanthine, the Company’s current 60 cancer screen was designed to investigate the impact of their patented cepharanthine formulation at concentrations that are predicted to be safe to patients 1. Epub 2010 Dec 17. 2011 Feb 7;8(1):260-9.

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

NYSE: AMAM), a position he previously held from 2010 through 2015. Unfortunately, this number is expected to increase rapidly with legalized marijuana and access to substances that have five times the THC concentration of regular marijuana,” said Mr. Allen. “We

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. 7) and 2018 ( n ?=?4),